Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/1/2011
New study highlights prevalence and therapeutic trends for diabetes in...
6/1/2011
Novo Nordisk to fend off competition by boosting China investments
5/27/2011
Park Nicollet launches Chinese diabetes care training project with San...
5/17/2011
India under pressure of growing API import from China
5/12/2011
China Initiative for Diabetes Excellence program launched with Sanofi ...
3/23/2011
Datamonitor: Chinese diabetes market to triple by 2019
3/16/2011
India pushes hard for better access to Chinese pharma market
2/17/2011
Market Snapshot - Leading Players of Chinese Diabetes Market
2/11/2011
Latest survey reveals high treatment costs of diabetes in China
2/9/2011
Takeda initiates clinical study of diabetes drug Alogliptin in China
1/28/2011
Will Asia's Insulin Makers Outperform Rivals in United States?
1/12/2011
Livzon claims victory in patent battle with India over bird flu herbal...
12/29/2010
Huadong Pharma acquires two diabetes drugs with CNY 25 million
12/15/2010
China and India to join hands to supply the global drug market
12/1/2010
New report: Chinese drug market for type II diabetes to reach US$2.5B ...
11/22/2010
Data Monitor: Chinese diabetes drug market to triple in next decade
11/19/2010
Cipla close to a global supply pact with Pfizer?
11/18/2010
CDS release survey of type II diabetes self-management by patients
11/16/2010
Pharma industry cooperation under discussion between leading Chinese a...
11/15/2010
China's diabetes prevalence and medical expenditures soar
11/2/2010
Eli Lilly establishes diabetes research center in Shanghai
11/1/2010
SFDA withdraws Sibutramine from the Chinese market
10/26/2010
Biocon eyes alternatives for Insugen after its China deal with Bayer t...
10/25/2010
PhRMA urges India for a better IP environment
10/20/2010
China initiates another major project for diabetes prevention and care
10/18/2010
China to keep Rosiglitazone on the market with conditions
10/13/2010
Chinese manufacturers of Sibutramine hang on to their products for now
9/26/2010
SFDA reviews ADRs of rosiglitazone-containing drugs after EMA and USFD...
9/20/2010
IMARC: the Chinese diabetes market to exceed US$ 2.8 Billion by 2015
9/6/2010
Bayer launches human recombinant insulin in China
Page:
15
/
19
Total number of articles:
544
:
[First]
[<<]
[13]
[14]
[15]
[16]
[17]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit